Overbought Stocks — Performance View · Biological Products, (No Diagnostic Substances)
8 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Performance columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–8 of 8
| TARS | Tarsus Pharmaceuticals, Inc. | +15.52% | +35.78% | +37.66% | +11.00% | +44.08% | +3.13% | 7.5% | 5.7% | 0.63 | 68K | 83.12 | +0.41% | 43K |
| APGE | Apogee Therapeutics, Inc. | +0.11% | +0.69% | +60.62% | +86.81% | +256.69% | +78.37% | 0.0% | 0.1% | 0.65 | 137K | 135.08 | +0.04% | 89K |
| ALVO | Alvotech | +9.82% | +43.01% | +43.97% | +29.24% | -32.58% | +7.51% | 3.8% | 5.2% | 0.94 | 79K | 5.37 | +0.56% | 74K |
| HALO | Halozyme Therapeutics, Inc. | +3.57% | +32.52% | +54.67% | +64.39% | +47.96% | +57.51% | 2.4% | 3.0% | 0.86 | 105K | 110.73 | +1.01% | 90K |
| ATTO | Attovia Therapeutics, Inc. | +23.14% | +22.69% | — | — | — | +19.37% | 10.7% | 10.0% | 0.60 | 39K | 25.33 | +3.56% | 23K |
| NVAX | Novavax Inc | +14.19% | +34.11% | +1.67% | +3.50% | +39.92% | +45.02% | 7.3% | 5.6% | 0.87 | 263K | 10.34 | +0.19% | 229K |
| CRDL | Cardiol Therapeutics Inc. | +4.61% | +60.22% | +85.78% | +114.43% | +96.80% | +117.35% | 7.0% | 7.2% | 1.26 | 52K | 2.15 | -0.23% | 66K |
| IOVA | Iovance Biotherapeutics, Inc. | +6.41% | +103.70% | +100.00% | +91.30% | +298.19% | +249.21% | 4.4% | 8.5% | 0.78 | 818K | 8.80 | +2.09% | 641K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.